US Patent Issued to OP-T on Nov. 18 for "Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD154 interaction" (Colorado Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,223, issued on Nov. 18, was assigned to OP-T LLC (Aurora, Colo.).

"Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD154 interaction" was invented by David Hal Wagner Jr. (Denver), Martin Glenn Yussman (Denver), Charles W. Henry (Denver) and Gisela M. Vaitaitis (Centennial, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and materials for treating and preventing autoimmune diseases, in particular, multiple sclerosis (MS) including small peptides are capable of interacting with CD40, thereby altering and/or modulating the ability of CD40 to interact with CD154, which apparently a...